Literature DB >> 6267587

Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.

K B Seamon, W Padgett, J W Daly.   

Abstract

The diterpene, forskolin [half-maximal effective concentration (EC50), 5-10 microM] activates adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] in rat cerebral cortical membranes in a rapid and reversible manner. Activation is not dependent on exogenous guanyl nucleotides and is not inhibited by guanosine 5'-O-(2-thiodiphosphate) when assayed with adenosine 5'-[beta, gamma-imido]triphosphate as substrate. GTP and GDP potentiate responses to forskolin. The activations of adenylate cyclase by forskolin and guanosine 5'-[beta, gamma-imido]triphosphate p[NH]ppG are not additive, whereas activations by forskolin and fluoride are additive or partially additive. The responses of adenylate cyclase to forskolin or fluoride are not inhibited by manganese ions, whereas the response to p[NH]ppG is completely blocked. Activation of adenylate cyclase by forskolin is considerably greater than the activation by fluoride in membranes from rat cerebellum, striatum, heart, and liver, while being about equal or less than the activation by fluoride in other tissues. Forskolin (EC50, 25 microM) causes a rapid and readily reversible 35-fold elevation of cyclic AMP in rat cerebral cortical slices that is not blocked by a variety of neurotransmitter antagonists. Low concentrations of forskolin (1 microM) augment the response of cyclic AMP-generating systems in brain slices to norepinephrine, isoproterenol, histamine, adenosine, prostaglandin E2, and vasoactive intestinal peptide. Forskolin would appear to activate adenylate cyclase through a unique mechanism involving both direct activation of the enzyme and facilitation or potentiation of the modulation of enzyme activity by receptors or the guanyl nucleotide-binding subunit, or both.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267587      PMCID: PMC319568          DOI: 10.1073/pnas.78.6.3363

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

Authors:  D M Gill; R Meren
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Reconstitution of catecholamine-sensitive adenylate cyclase. Association of a regulatory component of the enzyme with membranes containing the catalytic protein and beta-adrenergic receptors.

Authors:  A C Howlett; P C Sternweis; B A Macik; P M Van Arsdale; A G Gilman
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

3.  Endogenous GTP and the regulation of epinephrine stimulation of adenylate cyclase.

Authors:  R B Clark
Journal:  J Cyclic Nucleotide Res       Date:  1978-04

4.  Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system.

Authors:  D Cassel; T Pfeuffer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

5.  Reconstitution of cholera toxin-activated adenylate cyclase.

Authors:  G L Johnson; H R Kaslow; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

6.  Solubilization and conversion of hepatic adenylate cyclase to a form requiring MnATP as substrate.

Authors:  C Londos; P M Lad; T B Nielsen; M Rodbell
Journal:  J Supramol Struct       Date:  1979

7.  Physical and functional properties of adenylate cyclase from mature rat testis.

Authors:  E J Neer
Journal:  J Biol Chem       Date:  1978-08-25       Impact factor: 5.157

8.  Unique uncoupling of the frog erythrocyte adenylate cyclase system by manganese. Loss of hormone and guanine nucleotide-sensitive enzyme activities without loss of nucleotide-sensitive, high affinity agonist binding.

Authors:  L E Limbird; A R Hickey; R J Lefkowitz
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

9.  Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site.

Authors:  D Cassel; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.

Authors:  U Schwabe; M Miyake; Y Ohga; J W Daly
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

View more
  389 in total

1.  Effects of lead on adenylate cyclase activity in rat cerebral cortex.

Authors:  A L Rodrigues; A Regner; M A Rubin; D O Souza
Journal:  Neurochem Res       Date:  1999-08       Impact factor: 3.996

2.  Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.

Authors:  X Fang; S X Yu; Y Lu; R C Bast; J R Woodgett; G B Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release.

Authors:  M Okada; D J Nutt; T Murakami; G Zhu; A Kamata; Y Kawata; S Kaneko
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

4.  Modulation of an electrical synapse between solitary pairs of catfish horizontal cells by dopamine and second messengers.

Authors:  S H DeVries; E A Schwartz
Journal:  J Physiol       Date:  1989-07       Impact factor: 5.182

5.  Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment.

Authors:  J P Pégorier; M V Garcia-Garcia; C Prip-Buus; P H Duée; C Kohl; J Girard
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

6.  Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.

Authors:  P Correia-de-Sá; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

7.  Mechanistic insights into the activation of ester prodrugs of 666-15.

Authors:  Fuchun Xie; Pedro Martín-Acosta; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

8.  Interactive effects of isoprenaline, forskolin and acetylcholine on Ca2+ current in frog ventricular myocytes.

Authors:  R Fischmeister; A Shrier
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

9.  Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor.

Authors:  D E Vatner; S F Vatner; J Nejima; N Uemura; E E Susanni; T H Hintze; C J Homcy
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

10.  Differential sensitivity to cAMP among human cord and maternal/adult peripheral lymphocytes discloses differences between PHA- and OKT3-induced activation pathways.

Authors:  N Papadogiannakis; S A Johnsen; S Rosberg; R G Andersson; L B Olding
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.